athenahealth (Nasdaq:ATHN) offers another example of how it's important to separate a company from its stock. From the perspective of an operating company, there are a lot of positive things going on at this provider of software and services to medical practices. From a stock perspective, though, expectations are already red-hot and success is taken as a given, leaving little on the table for the future and significantly increasing the risk that any future earnings shortfall will be met with a painful sell-off in the shares.

Investopedia Broker Guides: Enhance your trading with the tools from today's top online brokers.

The Growth Story Remains the Same
The basic story at athenahealth hasn't changed all that much - the company needs to sign up more practices to use its athenaCollector revenue management product, while also increasing its sell-through and cross-selling efforts for platforms like Clinicals and Communicator.

As of the last quarter, the company continues to do well in that respect. Not only did the company post a 4% sequential growth in the number of physicians (22% growth year on year) and providers (21% growth year on year) using Collector, but user growth was considerably stronger in both Clinicals and Communicator. All of that helped to fuel a 38% rise in revenue, a result that was a bit ahead of generally bullish analyst expectations.

But so Does the Profitability Challenge
Although top-line growth looks great, doctors continue to sign up as customers and customer satisfaction and retention numbers remain strong, all is not perfect in athenahealth-land. Like many other software as a-service (SaaS) stories, including salesforce.com (NYSE:CRM), the cost of that growth is a more troublesome story.

Gross margin actually declined from last year on a GAAP basis, while operating income dropped. Although some investors may choose to focus on the non-GAAP measures that show growth (including a 27% growth in adjusted EBITDA), the 40% increase in sales and marketing expenses should not be ignored.

It's not enough to just pull customers away from Allscripts (Nasdaq:MDRX), General Electric (NYSE:GE), Siemens (NYSE:SI) or McKesson (NYSE:MCK), it also has to be a leveragable profit-making opportunity. While it may be unfair to compare SaaS providers across industries, and it is still early in the SaaS story, the ability to really leverage sales and marketing and post the sort of margins that traditional software and healthcare IT companies posted in the past seems like an open question.

SEE: A Look At Corporate Profit Margins

Separating Value and Shareholder Value
I don't argue that athenahealth delivers a good suite of products. The ability to update payor rules in real-time is valuable. Likewise, the ability to better manage the continuum of care, reduce errors, keep up with changes in legislation and improve care are all selling points.

Here again, though, is the difference between a "good company" and a "good stock." Penetrating larger enterprises has remained a challenge and healthcare IT is a ferociously competitive space, with more companies looking to enter the market with their own SaaS model.

The Bottom Line
On some level there's just a basic disconnect between growth and value investors. Accordingly, growth investors may well look at the reported revenue growth, increasing subscriber numbers and improving cross-sell metrics and argue that valuation is beside the point. And, at least for a while, they likely have a valid point.

Sooner or later, though, valuation always matters. Whether that's sooner (in the case of a shortfall in reported results or guidance) or later (as penetration rates reduce prospective growth rates), I do not know. But what I do know is that stocks trading at around a seven times trailing revenue are not buy-and-hold stocks, but rather buy-and-jump stocks that demand the ability to spot the point where the growth curve starts to flatten and get out before the Street and other growth investors turn on the name.

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen D. Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Investing

    The Rise of Corporate Venture Capital

    After the success of Google Ventures, corporate venture capital is an increasingly popular diversification and hedging tool for many large corporations.
  2. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  3. Investing

    What’s Plaguing Twitter and Yelp?

    Yelp and Twitter have recently become grounded in reality and unable to justify their sky-high stock valuations.
  4. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  5. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  6. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  7. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  8. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  9. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  10. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
RELATED FAQS
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!